{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T04:01:10Z","timestamp":1770177670452,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,3]]},"DOI":"10.7759\/cureus.102897","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T14:24:09Z","timestamp":1770128649000},"source":"Crossref","is-referenced-by-count":0,"title":["Purulent Pericarditis With Cardiac Tamponade Triggered by Left-Sided Infective Endocarditis in Active Systemic Lupus Erythematosus: A Case Report"],"prefix":"10.7759","author":[{"given":"Shunki","family":"Hiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos GC","year":"2020","unstructured":"Tsokos GC. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol. 2020, 21:605-14. 10.1038\/s41590-020-0677-6","journal-title":"Nat Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera R","year":"2003","unstructured":"Cervera R, Khamashta MA, Font J, et al.. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 2003, 82:299-308. 10.1097\/01.md.0000091181.93122.55","journal-title":"Medicine (Baltimore)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4166","article-title":"Pericarditis in lupus","volume":"11","author":"Dein E","year":"2019","unstructured":"Dein E, Douglas H, Petri M, Law G, Timlin H. Pericarditis in lupus. Cureus. 2019, 11:e4166. 10.7759\/cureus.4166","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12890\/2021_002658","article-title":"Purulent pericarditis: is it really a disease of the past?","volume":"8","author":"Costa L","year":"2021","unstructured":"Costa L, Carvalho D, Coelho E, Leal D, Lencastre L. Purulent pericarditis: is it really a disease of the past?. Eur J Case Rep Intern Med. 2021, 8:002658. 10.12890\/2021_002658","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01098-5","article-title":"Infective endocarditis","volume":"404","author":"Li M","year":"2024","unstructured":"Li M, Kim JB, Sastry BK, Chen M. Infective endocarditis. Lancet. 2024, 404:377-92. 10.1016\/S0140-6736(24)01098-5","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.4288","article-title":"Management of Staphylococcus aureus bacteremia: a review","volume":"334","author":"Tong SY","year":"2025","unstructured":"Tong SY, Fowler VG Jr, Skalla L, Holland TL. Management of Staphylococcus aureus bacteremia: a review. JAMA. 2025, 334:798-808. 10.1001\/jama.2025.4288","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2165\/00129784-200505020-00004","article-title":"Bacterial pericarditis: diagnosis and management","volume":"5","author":"Pankuweit S","year":"2005","unstructured":"Pankuweit S, Risti\u0107 AD, Seferovi\u0107 PM, Maisch B. Bacterial pericarditis: diagnosis and management. Am J Cardiovasc Drugs. 2005, 5:103-12. 10.2165\/00129784-200505020-00004","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2017-000221","article-title":"Associates and predictors of pleurisy or pericarditis in SLE","volume":"4","author":"Ryu S","year":"2017","unstructured":"Ryu S, Fu W, Petri MA. Associates and predictors of pleurisy or pericarditis in SLE. Lupus Sci Med. 2017, 4:e000221. 10.1136\/lupus-2017-000221","journal-title":"Lupus Sci Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-00984-1","article-title":"A review of complement activation in SLE","volume":"23","author":"Weinstein A","year":"2021","unstructured":"Weinstein A, Alexander RV, Zack DJ. A review of complement activation in SLE. Curr Rheumatol Rep. 2021, 23:16. 10.1007\/s11926-021-00984-1","journal-title":"Curr Rheumatol Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00055","article-title":"Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway","volume":"7","author":"Macedo AC","year":"2016","unstructured":"Macedo AC, Isaac L. Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway. Front Immunol. 2016, 7:55. 10.3389\/fimmu.2016.00055","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.08.002","article-title":"Complement deficiencies and dysregulation: pathophysiological consequences, modern analysis, and clinical management","volume":"114","author":"Schr\u00f6der-Braunstein J","year":"2019","unstructured":"Schr\u00f6der-Braunstein J, Kirschfink M. Complement deficiencies and dysregulation: pathophysiological consequences, modern analysis, and clinical management. Mol Immunol. 2019, 114:299-311. 10.1016\/j.molimm.2019.08.002","journal-title":"Mol Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320930097","article-title":"Clinical characteristics and long-term outcomes of Libman-Sacks endocarditis in patients with systemic lupus erythematosus","volume":"29","author":"Yoo BW","year":"2020","unstructured":"Yoo BW, Lee SW, Song JJ, Park YB, Jung SM. Clinical characteristics and long-term outcomes of Libman-Sacks endocarditis in patients with systemic lupus erythematosus. Lupus. 2020, 29:1115-20. 10.1177\/0961203320930097","journal-title":"Lupus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/00015385.2024.2445344","article-title":"Libman-Sacks endocarditis","volume":"80","author":"Hennebicq S","year":"2025","unstructured":"Hennebicq S, Silberberg D, Dubois P. Libman-Sacks endocarditis. Acta Cardiol. 2025, 80:658-9. 10.1080\/00015385.2024.2445344","journal-title":"Acta Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00797-8","article-title":"Vascular damage in systemic lupus erythematosus","volume":"20","author":"Ambler WG","year":"2024","unstructured":"Ambler WG, Kaplan MJ. Vascular damage in systemic lupus erythematosus. Nat Rev Nephrol. 2024, 20:251-65. 10.1038\/s41581-023-00797-8","journal-title":"Nat Rev Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2024-262764","article-title":"Abiotrophia defectiva endocarditis implicated in antineutrophil cytoplasmic antibody-negative glomerulonephritis","volume":"18","author":"Santos PW","year":"2025","unstructured":"Santos PW, Lopez YY. Abiotrophia defectiva endocarditis implicated in antineutrophil cytoplasmic antibody-negative glomerulonephritis. BMJ Case Rep. 2025, 18:e262764. 10.1136\/bcr-2024-262764","journal-title":"BMJ Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001205","article-title":"Streptococcus mutans-induced infective endocarditis associated with hypocomplementemia and positive anti-double-stranded DNA antibody","volume":"27","author":"Toda M","year":"2021","unstructured":"Toda M, Yamaguchi M, Katsuno T, et al.. Streptococcus mutans-induced infective endocarditis associated with hypocomplementemia and positive anti-double-stranded DNA antibody. J Clin Rheumatol. 2021, 27:e15-6. 10.1097\/RHU.0000000000001205","journal-title":"J Clin Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60060879","article-title":"Surgery for active infective endocarditis on mitral valve: anatomical, surgical, and disease factors as long-term outcome modifiers","volume":"60","author":"Berretta P","year":"2024","unstructured":"Berretta P, Bifulco O, Luthra S, et al.. Surgery for active infective endocarditis on mitral valve: anatomical, surgical, and disease factors as long-term outcome modifiers. Medicina (Kaunas). 2024, 60:879. 10.3390\/medicina60060879","journal-title":"Medicina (Kaunas)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour LM","year":"2015","unstructured":"Baddour LM, Wilson WR, Bayer AS, et al.. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015, 132:1435-86. 10.1161\/CIR.0000000000000296","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC guidelines for the management of endocarditis: developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM)","volume":"44","author":"Delgado V","year":"2023","unstructured":"Delgado V, Ajmone Marsan N, de Waha S, et al.. 2023 ESC guidelines for the management of endocarditis: developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM). Eur Heart J. 2023, 44:3948-4042. 10.1093\/eurheartj\/ehad193","journal-title":"Eur Heart J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis878","article-title":"Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke","volume":"56","author":"Barsic B","year":"2013","unstructured":"Barsic B, Dickerman S, Krajinovic V, et al.. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clin Infect Dis. 2013, 56:209-17. 10.1093\/cid\/cis878","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/456574-purulent-pericarditis-with-cardiac-tamponade-triggered-by-left-sided-infective-endocarditis-in-active-systemic-lupus-erythematosus-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T14:24:10Z","timestamp":1770128650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/456574-purulent-pericarditis-with-cardiac-tamponade-triggered-by-left-sided-infective-endocarditis-in-active-systemic-lupus-erythematosus-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.102897","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,3]]}}}